Quantcast

Rockville-based Novavax reports larger quarterly loss

Novavax Inc., of Rockville, a drug delivery company developing vaccines aimed at a broad range of infectious diseases worldwide, reported a net loss of $10 million, or 7 cents per diluted share, for the first quarter of 2013, compared to a net loss of $7.3 million, or 6 cents per share, for the year-ago period.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

 

[index]
[index]
[i]
[i]
[id, count]
[id, count]
[f.tagName.toLowerCase()]
[f.tagName.toLowerCase()]
[id, validationType, arg1, arg2]
[id, validationType, arg1, arg2]
[field.tagName.toLowerCase()]
[field.tagName.toLowerCase()]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]
[i]